This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ambit Biosciences Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Traci L Savall: Innovator in Pharmaceutical Formulations
Introduction
Traci L Savall is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of proliferative diseases. Her innovative work has led to the development of methods that enhance patient care and treatment efficacy.
Latest Patents
Traci L Savall holds 1 patent related to the administration of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or its pharmaceutically acceptable salts or solvates. This patent outlines specific dosing schedules and regimens for human patients, along with pharmaceutical formulations aimed at treating FLT-3 mediated diseases.
Career Highlights
Traci has established herself as a key figure in her field through her work at Ambit Biosciences Corporation. Her expertise in pharmaceutical formulations has been instrumental in advancing treatment options for patients suffering from various diseases.
Collaborations
Traci collaborates with notable colleagues, including Joyce K James and Shawn R Eichelberger, to further enhance the impact of her research and innovations.
Conclusion
Traci L Savall's contributions to pharmaceutical science exemplify her dedication to improving patient outcomes through innovative treatments. Her work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile